ReviewPharmaceutics2023

Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates.

Yani Berckmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.